LOGIN
Similar extended VTE prophylaxis efficacy and safety between rivaroxaban and aspirin following TJA
February 2019
Similar extended VTE prophylaxis efficacy and safety between rivaroxaban and aspirin following TJA
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty
N Engl J Med. 2018 Feb 22;378(8):699-707Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
3427 patients who had undergone either total knee or hip arthroplasty with a 5-day course of rivaroxaban 10mg postoperatively were randomized to extended thromboprophylaxis with either aspirin 81mg daily or continued rivaroxaban 10mg daily. Patients were assessed for the incidence of venous thromboembolism, major bleeding events, and clinically relevant nonmajor bleeding events over the first 90 d...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.